These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 16403100

  • 1. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
    Oyama N, Setterfield JF, Powell AM, Sakuma-Oyama Y, Albert S, Bhogal BS, Vaughan RW, Kaneko F, Challacombe SJ, Black MM.
    Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
    [Abstract] [Full Text] [Related]

  • 2. IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis.
    Horváth B, Niedermeier A, Podstawa E, Müller R, Hunzelmann N, Kárpáti S, Hertl M.
    Exp Dermatol; 2010 Jul 01; 19(7):648-53. PubMed ID: 20500772
    [Abstract] [Full Text] [Related]

  • 3. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
    Schmidt E, Skrobek C, Kromminga A, Hashimoto T, Messer G, Bröcker EB, Yancey KB, Zillikens D.
    Br J Dermatol; 2001 Nov 01; 145(5):778-83. PubMed ID: 11736901
    [Abstract] [Full Text] [Related]

  • 4. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production.
    Setterfield J, Theron J, Vaughan RW, Welsh KI, Mallon E, Wojnarowska F, Challacombe SJ, Black MM.
    Br J Dermatol; 2001 Sep 01; 145(3):406-14. PubMed ID: 11531829
    [Abstract] [Full Text] [Related]

  • 5. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity.
    Carrozzo M, Cozzani E, Broccoletti R, Carbone M, Pentenero M, Arduino P, Parodi A, Gandolfo S.
    J Periodontol; 2004 Oct 01; 75(10):1302-8. PubMed ID: 15562906
    [Abstract] [Full Text] [Related]

  • 6. Assessment of skin basement membrane zone antibodies in the urine of patients with acquired subepidermal immunobullous diseases.
    Allen J, Shears E, Powell J, Wojnarowska F.
    Br J Dermatol; 2001 Mar 01; 144(3):540-5. PubMed ID: 11260011
    [Abstract] [Full Text] [Related]

  • 7. Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230.
    Leverkus M, Bhol K, Hirako Y, Pas H, Sitaru C, Baier G, Bröcker EB, Jonkman MF, Ahmed AR, Zillikens D.
    Br J Dermatol; 2001 Dec 01; 145(6):998-1004. PubMed ID: 11899157
    [Abstract] [Full Text] [Related]

  • 8. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
    Christophoridis S, Büdinger L, Borradori L, Hunziker T, Merk HF, Hertl M.
    Br J Dermatol; 2000 Aug 01; 143(2):349-55. PubMed ID: 10951144
    [Abstract] [Full Text] [Related]

  • 9. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
    Natsuga K, Nishie W, Shinkuma S, Moriuchi R, Shibata M, Nishimura M, Hashimoto T, Shimizu H.
    Br J Dermatol; 2010 Mar 01; 162(3):513-7. PubMed ID: 19751242
    [Abstract] [Full Text] [Related]

  • 10. Integrin β4 is a major target antigen in pure ocular mucous membrane pemphigoid.
    Li X, Qian H, Sogame R, Hirako Y, Tsuruta D, Ishii N, Koga H, Tsuchisaka A, Jin Z, Tsubota K, Fukumoto A, Sotozono C, Kinoshita S, Hashimoto T.
    Eur J Dermatol; 2016 Jun 01; 26(3):247-53. PubMed ID: 27193492
    [Abstract] [Full Text] [Related]

  • 11. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180.
    Choi Y, Lee SE, Fukuda S, Hashimoto T, Kim SC.
    J Dermatol; 2011 Feb 01; 38(2):169-72. PubMed ID: 21269314
    [Abstract] [Full Text] [Related]

  • 12. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype.
    Metz BJ, Ruggeri SY, Hsu S, Reed JA, Ghohestani AS, Uitto J, Ghohestani RF.
    Int J Dermatol; 2004 Jun 01; 43(6):443-6. PubMed ID: 15186228
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The immunoglobulin A antibody response in clinical subsets of mucous membrane pemphigoid.
    Egan CA, Taylor TB, Meyer LJ, Petersen MJ, Zone JJ.
    Dermatology; 1999 Jun 01; 198(4):330-5. PubMed ID: 10449929
    [Abstract] [Full Text] [Related]

  • 16. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N, Fujimoto M, Watanabe R, Nakashima H, Kuwano Y, Yazawa N, Echigo T, Okochi H, Tamaki K.
    J Dermatol Sci; 2008 Feb 01; 49(2):153-61. PubMed ID: 17920818
    [Abstract] [Full Text] [Related]

  • 17. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M, Hashimoto T, Dykes PJ, Nishikawa T.
    Clin Exp Dermatol; 1996 Jan 01; 21(1):23-7. PubMed ID: 8689764
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses.
    Feliciani C, Caldarola G, Kneisel A, Podstawa E, Pfütze M, Pfützner W, Hertl M.
    Br J Dermatol; 2009 Aug 01; 161(2):306-12. PubMed ID: 19485996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.